From Hand-Crafted to Deep Learning-Based Cancer Radiomics

Total Page:16

File Type:pdf, Size:1020Kb

Load more

2 Radiomics consists of a wide range of (partially intercon- nected) research areas with each individual branch possibly worth a complete exploration, the purpose of this article is to provide an inclusive introduction to Radiomics for the signal processing community, as such, we will focus on the progression of signal processing algorithms within the context of Radiomics. In brief, we aim to present an overview of the current state, opportunities, and challenges of Radiomics from signal processing perspective to facilitate further advancement and innovation in this critical multidisciplinary research area. As such, the article will cover the following four main areas: (i) Hand-crafted Radiomics, where we introduce and in- Fig. 1: Increasing interest in Radiomics based on data from Google vestigate different feature extraction, feature reduction, Scholar (“Radiomics” is used as the keyword). It is observed that and classification approaches used within the context there is an increasing interest in both types of the Radiomics. of Radiomics. Most of the techniques utilized in any as cancer stage. This clinical study has illustrated/validated of the aforementioned steps lie within the broad area effectiveness of Radiomics for tumor related predictions and of “Machine Learning,” where the goal is to improve showed that Radiomics has the capability to identify lung the performance of different computational models using and head-and-neck cancers from a single-time point CT scan. past experiences (data) [17]. In other words, the underly- Consequently, there has been a recent surge of interest [8]– ing models are capable of learning from past data, lead- [12] on this multidisciplinary research area as Radiomics has ing to the automatic process of prediction and diagno- the potential to provide significant assistance for assessing sis. Furthermore, since hundreds of Radiomics features the risk of recurrence of cancer [13]; Evaluating the risk are extracted, an appropriate feature selection/extraction of radiation-induced side-effects on non-cancer tissues [14], strategy should be adopted to reduce the “curse of and; Predicting the risk for cancer development in healthy dimensionality” and overfitting of the prediction models. subjects [14]. In a very recent article by Vallieres et al. [16], it Most of these strategies, themselves, lie within the field is shown that the Radiomics features extracted in Reference [5] of “Machine Learning”, as they are aimed to learn the have a noticeable dependency on the tumor volume, which best set of features, based on the available data. is a strong prognostic factor, and revised calculations are (ii) Deep learning-based Radiomics, where we provide an proposed that are less correlated to the tumor volume. In other overview of different deep architectures used in Ra- words, more powerful Radiomics features and procedures are diomics along with interpretability requirements. being introduced, illustrating the ongoing research potentials (iii) Hybrid solutions developed to simultaneously benefit of Radiomics. from the advantages of each of the above two mentioned The key underlying hypothesis in the Radiomics is that categories. the constructed descriptive models (based on medical imaging (iv) Challenges, Open Problems, and Opportunities, where data, sometimes complemented by biological and/or medical we focus on the limitations of processing techniques data) are capable of providing relevant and beneficial predic- unique in nature to the Radiomics, and introduce open tive, prognostic, and/or diagnostic information. In this regard, problems and potential opportunities for signal process- one can identify two main categories of Radiomics. Con- ing researchers. ventional pipeline based on Hand-Crafted Radiomic features Fig. 1 shows the increasing interest in Radiomics within the (HCR) that consists of the following four main processing research community. Although there have been few recent arti- tasks: (i) Image acquisition/reconstruction; (ii) Image segmen- cles [3], [18] reviewing and introducing Radiomics, to the best tation; (iii) Feature extraction and quantification, and; (iv) of our knowledge, most of them are from outside the signal Statistical analysis and model building. On the other hand, the processing (SP) community. References within the SP society Deep Learning-based Radiomics (DLR) pipeline has recently such as the work by J. Edwards [19] have investigated recent emerged which differs from the former category since deep advancements in medical imaging devices and technologies networks do not necessarily need the segmented Region Of without reviewing the role of Radiomics in medical applica- Interest (ROI), and their feature extraction and analysis parts tions. Other existing papers outside SP community (e.g., [3]) are partially or fully coupled. We will elaborate on these have failed to clearly describe the underlying signal processing properties in section IV. technologies and have narrowed down their scope only to More clinical studies are being approved and conducted hand-crafted Radiomics and its diagnosis capability. While to further investigate and advance the unparalleled oppor- Reference [18] has briefly touched upon the deep learning tunities the Radiomics posed to offer for clinical applica- pipeline as an emerging technology that can extract Radiomics tions. Information Post I provides an overview of different features, it has not studied applicability of different deep screening technologies used within the Radiomics pipeline architectures [20] and left the interpretability topic untouched. along with supporting data sources and available datasets to Furthermore, Reference [21] has mostly focused on the hand- develop Radiomics-based predictive/prognostic models. While crafted Radiomics, while deep learning-based Radiomics is 3 explained briefly without addressing different architectures, especially since SP is one of the main building blocks of the interpretability, and hybrid models. Although both types of Radiomics. Radiomics are covered in Reference [22], combination of The reminder of this article is organized as follows: first in hand-crafted and deep learning-based features are not con- Section II, we will discuss several applications of Radiomics sidered. Besides, challenges associated with Radiomics and in cancer-related fields, followed by Hand-Crafted solutions in the relation between Radiomics and gene-expression (Radio- Section III. The Deep learning-based Radiomics is presented genomics) are also not discussed thoroughly. Finally, the scope in Section IV, where several aspects of DLR is investigated. In of Reference [23] is limited to deep learning-based Radiomics, Section V, we explain different hybrid solutions to Radiomics, without addressing hand-crafted features, their stability, hybrid which aim to take advantage of both DLR and HCR. Finally in Radiomics, and Radiogenomics. All these call for an urgent Section VI various challenges and opportunities of Radiomics, and timely quest to introduce Radiomics to our community especially for SP community, are discussed. We conclude our work is Section VII. 4 Information Post I: Radiomics Supporting Resources Several potential medical resources provide information to the • Magnetic Resonance Imaging (MRI): Unlike CT, proper- Radiomics pipeline, some of which are directly used to extract ties of MRI images are not directly associated with tissue Radiomics features and some serve the decision making process, density and specific methods are required to obtain the so- as complementary information sets. Below we review the most called signal intensity. Besides, several imager and vendor- important data resources for Radiomics. dependant factors such as gradient and coil systems [26], pulse sequence design, slice thickness, and other parameters Screening Technologies: The Radiomics features can be ex- such as artifacts and magnetic field strength affect the prop- tracted from several imaging modalities, among which the fol- erties of the MRI images [2], which should be consistent lowing are the most commonly used modalities: across different institutions. • Computed Tomography (CT) Scans: The CT is the modal- ity of choice for the diagnosis of many diseases in dif- ferent parts of the body, and by providing high resolution images [1] paves the path for extracting comparable Ra- diomics features. Nonetheless, the CT imaging performance depends on different components of the utilized protocol including the following three main properties: (i) Slice thickness, which is the distance in millimeter (mm) between two consecutive slices; (ii) The capability for projecting the density variations into image intensities, and; (iii) Re- construction algorithm, which aims at converting tomo- Complimentary Data Sources: In addition to imaging resources, graphic measurements to cross-sectional images. Although the following clinical data sources are typically combined with CT protocols for specific clinical indications are usually Radiomics features: similar across different institutions, Radiomics features can even differ between different scanners with the same set- • Gene expression: The process of converting DNA to func- tings [24]. Therefore, there is still a considerable need to tional product to have a global insight of cellular function. ensure consistency of Radiomics feature extraction amongst • Clinical characteristics: Patient’s characteristics such age, different scanners and imaging protocols [2]. CT images gender, and past medical
Recommended publications
  • Intro to Radiomics

    Intro to Radiomics

    Downloaded from jnm.snmjournals.org by on June 23, 2020. For personal use only. CONTINUING EDUCATION Introduction to Radiomics Marius E. Mayerhoefer1,2, Andrzej Materka3, Georg Langs2, Ida H¨aggstr¨om4, Piotr Szczypinski´ 3, Peter Gibbs1, and Gary Cook5,6 1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; 2Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria; 3Institute of Electronics, Lodz University of Technology, Lodz, Poland; 4Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; 5Cancer Imaging Department, School of Biomedical Engineering and Imaging Sciences, King’s College London, London, United Kingdom; and 6King’s College London and Guy’s and St. Thomas’ PET Centre, St. Thomas’ Hospital, London, United Kingdom Learning Objectives: On successful completion of this activity, participants should be able to (1) describe the standard radiomics workflow; (2) know the basic concepts of radiomic feature classes; and (3) recognize common limitations and pitfalls in radiomics studies. Financial Disclosure: Dr. Mayerhoefer has received speaker honoraria and research support from Siemens Healthineers and speaker honoraria from Bristol- Myers Squibb. Dr. Langs is an employee and shareholder of contextflow GmbH. The authors of this article have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest. CME Credit: SNMMI is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing education for physicians. SNMMI designates each JNM continuing education article for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity.
  • Radiomics-Based Prediction of Overall Survival in Lung Cancer Using Different Volumes-Of-Interest

    Radiomics-Based Prediction of Overall Survival in Lung Cancer Using Different Volumes-Of-Interest

    applied sciences Article Radiomics-Based Prediction of Overall Survival in Lung Cancer Using Different Volumes-Of-Interest Natascha Claudia D’Amico 1,2, Rosa Sicilia 1,* , Ermanno Cordelli 1, Lorenzo Tronchin 1 , Carlo Greco 3, Michele Fiore 3 , Alessia Carnevale 3, Giulio Iannello 1 , Sara Ramella 3 and Paolo Soda 1 1 Unit of Computer Systems and Bioinformatics, Department of Engineering, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128 Rome, Italy; [email protected] (N.C.D.); [email protected] (E.C.); [email protected] (L.T.); [email protected] (G.I.); [email protected] (P.S.) 2 Department of Diagnostic Imaging and Sterotactic Radiosurgey, Centro Diagnostico Italiano S.p.A., Via S. Saint Bon 20, 20147 Milan, Italy 3 Radiation Oncology, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128 Rome, Italy; [email protected] (C.G.); m.fi[email protected] (M.F.); [email protected] (A.C.); [email protected] (S.R.) * Correspondence: [email protected]; Tel.: +39-06-225419622 Received: 14 August 2020; Accepted: 11 September 2020; Published: 15 September 2020 Featured Application: The manuscript aims to provide a signature to predict Overall Survival in patients with Locally Advanced Non-Small Cell Lung Cancer. The results could offer the physicians advanced software tools to early evaluate the disease evolution before the treatment start so to personalize each patient’s therapy. Moreover, this work provides insight into the use of the different segmentation volumes usually applied in radiation oncology. Abstract: Lung cancer accounts for the largest amount of deaths worldwide with respect to the other oncological pathologies.
  • Evaluation of Shape and Textural Features from CT As Prognostic

    Evaluation of Shape and Textural Features from CT As Prognostic

    ANTICANCER RESEARCH 38 : 2155-2160 (2018) doi:10.21873/anticanres.12456 Evaluation of Shape and Textural Features from CT as Prognostic Biomarkers in Non-small Cell Lung Cancer FRANCESCO BIANCONI 1, MARIO LUCA FRAVOLINI 1, RAQUEL BELLO-CEREZO 1, MATTEO MINESTRINI 2, MICHELE SCIALPI 2 and BARBARA PALUMBO 2 Departments of 1Engineering, and 2Surgical and Biomedical Sciences, University of Perugia, Perugia, Italy Abstract. Background/Aim. We retrospectively investigated Computed tomography (CT) is usually the front-line imaging the prognostic potential (correlation with overall survival) approach in many neoplastic disorders, and, as such, also the of 9 shape and 21 textural features from non-contrast- primary source of baseline data for most patients with NSCLC. enhanced computed tomography (CT) in patients with non- The use of CT-derived features as potential biomarkers to small-cell lung cancer. Materials and Methods. We predict survival in patients with NSCLC has, therefore, elicited considered a public dataset of 203 individuals with intense research interest in recent years (7-8). inoperable, histologically- or cytologically-confirmed Ganeshan and Miles were among the first to suggest that NSCLC. Three-dimensional shape and textural features from textural features from CT could be correlated with tumour CT were computed using proprietary code and their metabolism and stage (4). Since then various authors have prognostic potential evaluated through four different investigated the subject obtaining different – sometimes statistical protocols. Results. Volume and grey-level run diverging – results. Aerts et al. for instance analysed 440 length matrix (GLRLM) run length non-uniformity were the radiomic features on a dataset of 1,019 individuals with lung only two features to pass all four protocols.
  • Identifying Robust Radiomics Features for Lung Cancer by Using In-Vivo and Phantom Lung Lesions

    Identifying Robust Radiomics Features for Lung Cancer by Using In-Vivo and Phantom Lung Lesions

    Article Identifying Robust Radiomics Features for Lung Cancer by Using In-Vivo and Phantom Lung Lesions Lin Lu †, Shawn H. Sun † , Aaron Afran, Hao Yang, Zheng Feng Lu ‡, James So, Lawrence H. Schwartz and Binsheng Zhao * Department of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA; [email protected] (L.L.); [email protected] (S.H.S.); [email protected] (A.A.); [email protected] (H.Y.); [email protected] (Z.F.L.); [email protected] (J.S.); [email protected] (L.H.S.) * Correspondence: [email protected] † These authors contributed equally to this work. ‡ Current address: Department of Radiology, The University of Chicago, Chicago, IL 60637, USA. Abstract: We propose a novel framework for determining radiomics feature robustness by consid- ering the effects of both biological and noise signals. This framework is preliminarily tested in a study predicting the epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients. Pairs of CT images (baseline, 3-week post therapy) of 46 NSCLC patients with known EGFR mutation status were collected and a FDA-customized anthropomorphic thoracic phantom was scanned on two vendors’ scanners at four different tube currents. Delta radiomics features were extracted from the NSCLC patient CTs and reproducible, non-redundant, and informative features were identified. The feature value differences between EGFR mutant and EGFR wildtype patients were quantitatively measured as the biological signal. Similarly, radiomics features were extracted from the phantom CTs. A pairwise comparison between settings resulted in a feature value difference that was quantitatively measured as the noise signal.
  • Preliminary Report on Computed Tomography Radiomics Features As Biomarkers to Immunotherapy Selection in Lung Adenocarcinoma Patients

    Preliminary Report on Computed Tomography Radiomics Features As Biomarkers to Immunotherapy Selection in Lung Adenocarcinoma Patients

    cancers Article Preliminary Report on Computed Tomography Radiomics Features as Biomarkers to Immunotherapy Selection in Lung Adenocarcinoma Patients Vincenza Granata 1, Roberta Fusco 2,*, Matilde Costa 3, Carmine Picone 1, Diletta Cozzi 4,5 , Chiara Moroni 4, Giorgia Viola La Casella 6, Agnese Montanino 7, Riccardo Monti 6, Francesca Mazzoni 8, Roberta Grassi 5,6, Valeria Grazia Malagnino 9, Salvatore Cappabianca 6, Roberto Grassi 5,6, Vittorio Miele 4,5 and Antonella Petrillo 1 1 Division of Radiology, Istituto Nazionale Tumori IRCCS Fondazione Pascale—IRCCS di Napoli, I-80131 Naples, Italy; [email protected] (V.G.); [email protected] (C.P.); [email protected] (A.P.) 2 Medical Oncology Division, Igea SpA, I-80013 Naples, Italy 3 R & D Lab. of Tecnologie Avanzate TA Srl, Science and Technology Park, I-10153 Udine, Italy; [email protected] 4 Division of Radiodiagnostic, Azienda Ospedaliero-Universitaria Careggi, I-50134 Firenze, Italy; [email protected] (D.C.); [email protected] (C.M.); [email protected] (V.M.) 5 Italian Society of Medical and Interventional Radiology (SIRM), SIRM Foundation, I-20122 Milan, Italy; [email protected] (R.G.); [email protected] (R.G.) 6 Citation: Granata, V.; Fusco, R.; Division of Radiodiagnostic, Università degli Studi della Campania Luigi Vanvitelli, I-80128 Naples, Italy; [email protected] (G.V.L.C.); [email protected] (R.M.); Costa, M.; Picone, C.; Cozzi, D.; [email protected] (S.C.) Moroni, C.; La Casella, G.V.; 7 Thoracic Medical Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale—IRCCS di Napoli, Montanino, A.; Monti, R.; Mazzoni, F.; I-80131 Naples, Italy; [email protected] et al.
  • Repeatability of Multiparametric Prostate MRI Radiomics Features

    Repeatability of Multiparametric Prostate MRI Radiomics Features

    Repeatability of Multiparametric Prostate MRI Radiomics Features Authors Michael Schwier,1,2 Joost van Griethuysen,3 Mark G Vangel,2,4 Steve Pieper,5 Sharon Peled,2,3 Clare M 1,2 ​ 2,6 1,2​ ​ 1,2,6 ​ 1,2 ​ Tempany, ​ Hugo JWL Aerts, ​ Ron Kikinis, ​ Fiona M Fennessy, ​ and Andrey Fedorov ​ ​ ​ ​ ​ Contact: [email protected], [email protected] ​ ​ ​ ​ 1 B​ righam and Women's Hospital, Boston, MA, United States 2 H​ arvard Medical School, Boston, MA, United States 3 N​ etherlands Cancer Institute Maastricht University, Amsterdam, Netherlands 4 M​ assachusetts General Hospital, Charlestown, MA, United States 5 I​ somics, Inc., Cambridge, MA, United States 6 D​ ana-Farber Cancer Institute, Boston, MA, United States Abstract In this study we assessed the repeatability of the values of radiomics features for small prostate tumors using test-retest Multiparametric Magnetic Resonance Imaging (mpMRI) images. The premise of radiomics is that quantitative image features can serve as biomarkers characterizing disease. For such biomarkers to be useful, repeatability is a basic requirement, meaning its value must remain stable between two scans, if the conditions remain stable. We investigated repeatability of radiomics features under various preprocessing and extraction configurations including various image normalization schemes, different image pre-filtering, 2D vs 3D texture computation, and different bin widths for image discretization. Image registration as means to re-identify regions of interest across time points was evaluated against human-expert segmented regions in both time points. Even though we found many radiomics features and preprocessing combinations with a high repeatability (Intraclass Correlation Coefficient (ICC) > 0.85), our results indicate that overall the repeatability is highly sensitive to the processing parameters (under certain configurations, it can be below 0.0).
  • Radiomics in Oncology, Part 1: Technical Principles and Gastrointestinal Application in CT and MRI

    Radiomics in Oncology, Part 1: Technical Principles and Gastrointestinal Application in CT and MRI

    cancers Review Radiomics in Oncology, Part 1: Technical Principles and Gastrointestinal Application in CT and MRI Damiano Caruso 1 , Michela Polici 1 , Marta Zerunian 1 , Francesco Pucciarelli 1 , Gisella Guido 1 , Tiziano Polidori 1, Federica Landolfi 1, Matteo Nicolai 1, Elena Lucertini 1, Mariarita Tarallo 2 , Benedetta Bracci 1, Ilaria Nacci 1, Carlotta Rucci 1, Elsa Iannicelli 1 and Andrea Laghi 1,* 1 Radiology Unit, Department of Medical Surgical Sciences and Translational Medicine, Sapienza University of Rome-Sant’Andrea University Hospital, Via di Grottarossa, 1035-1039, 00189 Rome, Italy; [email protected] (D.C.); [email protected] (M.P.); [email protected] (M.Z.); [email protected] (F.P.); [email protected] (G.G.); [email protected] (T.P.); [email protected] (F.L.); [email protected] (M.N.); [email protected] (E.L.); [email protected] (B.B.); [email protected] (I.N.); [email protected] (C.R.); [email protected] (E.I.) 2 Department of Surgery “Pietro Valdoni”, Sapienza University of Rome-Umberto I University Hospital, Viale del Policlinico, 155, 00161 Rome, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-063-377-5285 Simple Summary: Part I is an overview aimed to investigate some technical principles and the main Citation: Caruso, D.; Polici, M.; fields of radiomic application in gastrointestinal oncologic imaging (CT and MRI) with a focus on Zerunian, M.; Pucciarelli, F.; Guido, G.; Polidori, T.; Landolfi, F.; Nicolai, diagnosis, prediction prognosis, and assessment of response to therapy in gastrointestinal cancers, M.; Lucertini, E.; Tarallo, M.; et al.
  • The Impact of the Variation of Imaging Factors on the Robustness of Computed Tomography Radiomic Features: a Review

    The Impact of the Variation of Imaging Factors on the Robustness of Computed Tomography Radiomic Features: a Review

    medRxiv preprint doi: https://doi.org/10.1101/2020.07.09.20137240; this version posted July 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. The impact of the variation of imaging factors on the robustness of Computed Tomography Radiomic Features: A review Reza Reiazi1,2,3, Engy Abbas4, Petra Famiyeh1,5, Aria Rezaie1, Jennifer Y. Y. Kwan1, Tirth Patel9, Scott V Bratman1,3, Tony Tadic1,3, Fei-Fei Liu1,3, Benjamin Haibe-Kains1,2,6,7,8* 1Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. 2Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. 3Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada 4Joint Department of Medical Imaging, University of Toronto, Toronto, Canada 5 Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. 6Ontario Institute for Cancer Research, Toronto, Ontario, Canada. 7Department of Computer Science, University of Toronto, Toronto, Ontario, Canada. 8Vector Institute, Toronto, Ontario, Canada. 9Techna Institute, University Health Network, Toronto, Ontario, Canada * Author to whom correspondence should be addressed. Benjamin HAIBE-KAINS, PhD. Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Phone: +1 416 581 8626. E-mail: [email protected] 1 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.07.09.20137240; this version posted July 11, 2020.
  • Radiomics in Oncology, Part 2: Thoracic, Genito-Urinary, Breast, Neurological, Hematologic and Musculoskeletal Applications

    Radiomics in Oncology, Part 2: Thoracic, Genito-Urinary, Breast, Neurological, Hematologic and Musculoskeletal Applications

    cancers Review Radiomics in Oncology, Part 2: Thoracic, Genito-Urinary, Breast, Neurological, Hematologic and Musculoskeletal Applications Damiano Caruso 1 , Michela Polici 1 , Marta Zerunian 1 , Francesco Pucciarelli 1, Gisella Guido 1 , Tiziano Polidori 1, Federica Landolfi 1, Matteo Nicolai 1, Elena Lucertini 1, Mariarita Tarallo 2 , Benedetta Bracci 1, Ilaria Nacci 1, Carlotta Rucci 1, Marwen Eid 3, Elsa Iannicelli 1 and Andrea Laghi 1,* 1 Radiology Unit, Department of Medical Surgical Sciences and Translational Medicine, Sapienza University of Rome-Sant’Andrea University Hospital, Via di Grottarossa, 1035-1039, 00189 Rome, Italy; [email protected] (D.C.); [email protected] (M.P.); [email protected] (M.Z.); [email protected] (F.P.); [email protected] (G.G.); [email protected] (T.P.); [email protected] (F.L.); [email protected] (M.N.); [email protected] (E.L.); [email protected] (B.B.); [email protected] (I.N.); [email protected] (C.R.); [email protected] (E.I.) 2 Department of Surgery “Pietro Valdoni”, Sapienza University of Rome, 00161 Rome, Italy; [email protected] 3 Internal Medicine, Northwell Health Staten Island University Hospital, Staten Island, New York, NY 10305, USA; [email protected] * Correspondence: [email protected]; Tel.: +39-0633775285 Simple Summary: This Part II is an overview of the main applications of Radiomics in oncologic Citation: Caruso, D.; Polici, M.; imaging with a focus on diagnosis, prognosis prediction and assessment of response to therapy in Zerunian, M.; Pucciarelli, F.; Guido, thoracic, genito-urinary, breast, neurologic, hematologic and musculoskeletal oncology.
  • Identification of Non–Small Cell Lung Cancer Sensitive to Systemic

    Identification of Non–Small Cell Lung Cancer Sensitive to Systemic

    Published OnlineFirst March 20, 2020; DOI: 10.1158/1078-0432.CCR-19-2942 CLINICAL CANCER RESEARCH | PRECISION MEDICINE AND IMAGING Identification of Non–Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics Laurent Dercle1,2, Matthew Fronheiser3, Lin Lu1, Shuyan Du3, Wendy Hayes3, David K. Leung3, Amit Roy4, Julia Wilkerson5, Pingzhen Guo1, Antonio T. Fojo6, Lawrence H. Schwartz1, and Binsheng Zhao1 ABSTRACT ◥ Purpose: Using standard-of-care CT images obtained from progression-free survival (NCT01642004, NCT01721759) or sur- patients with a diagnosis of non–small cell lung cancer (NSCLC), gery (NCT00588445). Machine learning was implemented to select we defined radiomics signatures predicting the sensitivity of tumors up to four features to develop a radiomics signature in the training to nivolumab, docetaxel, and gefitinib. datasets and applied to each patient in the validation datasets to Experimental Design: Data were collected prospectively classify treatment sensitivity. and analyzed retrospectively across multicenter clinical trials Results: The radiomics signatures predicted treatment sensitivity [nivolumab, n ¼ 92, CheckMate017 (NCT01642004), Check- in the validation dataset of each study group with AUC (95 Mate063 (NCT01721759); docetaxel, n ¼ 50, CheckMate017; gefi- confidence interval): nivolumab, 0.77 (0.55–1.00); docetaxel, 0.67 tinib, n ¼ 46, (NCT00588445)]. Patients were randomized to (0.37–0.96); and gefitinib, 0.82 (0.53–0.97). Using serial radiograph- training or validation cohorts using either a 4:1 ratio (nivolumab: ic measurements, the magnitude of exponential increase in signa- 72T:20V) or a 2:1 ratio (docetaxel: 32T:18V; gefitinib: 31T:15V) ture features deciphering tumor volume, invasion of tumor bound- to ensure an adequate sample size in the validation set.
  • An Exploratory Study on the Stable Radiomics Features of Metastatic Small Pulmonary Nodules in Colorectal Cancer Patients

    An Exploratory Study on the Stable Radiomics Features of Metastatic Small Pulmonary Nodules in Colorectal Cancer Patients

    ORIGINAL RESEARCH published: 16 July 2021 doi: 10.3389/fonc.2021.661763 An Exploratory Study on the Stable Radiomics Features of Metastatic Small Pulmonary Nodules in Colorectal Cancer Patients Caiyin Liu 1, Qiuhua Meng 1*, Qingsi Zeng 1, Huai Chen 1, Yilian Shen 1, Biaoda Li 2, Renli Cen 1, Jiongqiang Huang 3, Guangqiu Li 4, Yuting Liao 5 and Tingfan Wu 5 1 Department of Radiology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China, 2 Department of Radiology, Shenzhen Hospital, University of Hong Kong, Shenzhen, China, 3 Department of Gastrointestinal Surgery, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China, 4 Department of Pathology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China, 5 Department of Pharmaceutical Diagnostics, GE Healthcare (China), Shanghai, China Objectives: To identify the relatively invariable radiomics features as essential Edited by: characteristics during the growth process of metastatic pulmonary nodules with a Miguel Angel Gonzalez Ballester, diameter of 1 cm or smaller from colorectal cancer (CRC). Pompeu Fabra University, Spain Reviewed by: Methods: Three hundred and twenty lung nodules were enrolled in this study (200 CRC Arnav Bhavsar, metastatic nodules in the training cohort, 60 benign nodules in the verification cohort 1, 60 Indian Institute of Technology Mandi, fi India CRC metastatic nodules in the veri cation cohort 2). All the nodules were divided into four Sang Hyun Park, groups according to the maximum diameter: 0 to 0.25 cm, 0.26 to 0.50 cm, 0.51 to Daegu Gyeongbuk Institute of Science 0.75 cm, 0.76 to 1.0 cm. These pulmonary nodules were manually outlined in computed and Technology (DGIST), South Korea *Correspondence: tomography (CT) images with ITK-SNAP software, and 1724 radiomics features were Qiuhua Meng extracted.
  • Radiomics: the Facts and the Challenges of Image Analysis

    Radiomics: the Facts and the Challenges of Image Analysis

    Rizzo et al. European Radiology Experimental (2018) 2:36 European Radiology https://doi.org/10.1186/s41747-018-0068-z Experimental NARRATIVEREVIEW Open Access Radiomics: the facts and the challenges of image analysis Stefania Rizzo1* , Francesca Botta2, Sara Raimondi3, Daniela Origgi2, Cristiana Fanciullo4, Alessio Giuseppe Morganti5 and Massimo Bellomi6 Abstract Radiomics is an emerging translational field of research aiming to extract mineable high-dimensional data from clinical images. The radiomic process can be divided into distinct steps with definable inputs and outputs, such as image acquisition and reconstruction, image segmentation, features extraction and qualification, analysis, and model building. Each step needs careful evaluation for the construction of robust and reliable models to be transferred into clinical practice for the purposes of prognosis, non-invasive disease tracking, and evaluation of disease response to treatment. After the definition of texture parameters (shape features; first-, second-, and higher- order features), we briefly discuss the origin of the term radiomics and the methods for selecting the parameters useful for a radiomic approach, including cluster analysis, principal component analysis, random forest, neural network, linear/logistic regression, and other. Reproducibility and clinical value of parameters should be firstly tested with internal cross-validation and then validated on independent external cohorts. This article summarises the major issues regarding this multi-step process, focussing in particular on challenges of the extraction of radiomic features from data sets provided by computed tomography, positron emission tomography, and magnetic resonance imaging. Keywords: Clinical decision-making, Biomarkers, Image processing (computer-assisted), Radiomics, Texture analysis Key points with or without associated gene expression to support evidence-based clinical decision-making [1].